We could demonstrate that this, first, we had to demonstrate that it actually worked in people
5 Star Patient Reviews Great people and very professional
Kevin Sheng-Kai Ma, DDS, FRSPH, FRSM, international scholar at the Center for Global Health at the Perelman School of Medicine at the University of Pennsylvania and lead author of this study, told Medical News Today that he and his colleagues were not surprised by these findings, as these [obesity and obesity-related issues] are indications for GLP-1RA that have been approved in recent years. That said, clinicians are encouraged to monitor and continue assessing patients receiving GLP-1RA [drugs], he advised
Like other glucagon-like peptide-1 receptor agonists, the semaglutide in Ozempic pretends to be GLP-1, which in turn increases insulin output
Why is a Pharmacy Benefit Manager (PBM) commenting on this